(19)
(11) EP 3 993 873 A1

(12)

(43) Date of publication:
11.05.2022 Bulletin 2022/19

(21) Application number: 20834735.1

(22) Date of filing: 02.07.2020
(51) International Patent Classification (IPC): 
A61P 31/14(2006.01)
A61K 39/21(2006.01)
A61P 31/12(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 31/12; A61P 31/14; C12N 2740/12034; A61K 39/12; A61K 2039/812
(86) International application number:
PCT/US2020/040742
(87) International publication number:
WO 2021/003421 (07.01.2021 Gazette 2021/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 02.07.2019 US 201916460295
13.11.2019 US 201962934858 P

(71) Applicant: Virago Vax Inc.
New York, NY 10022 (US)

(72) Inventor:
  • BARTSICH, Sophie
    New York, New York 10022 (US)

(74) Representative: Sunderic, Bojan 
Terazije 29
11000 Beograd
11000 Beograd (RS)

   


(54) MAMMARY TUMOR VIRUS SUPPRESSION